If you are looking for guidance based on this study's results:
To determine if continuous low-dose chemotherapy after a transplant could improve overall survival and keep the disease controlled for longer periods. IFM_05-May 2022
The (often referred to simply as the IFM-05 study) focused on using lenalidomide as a maintenance treatment. If you are looking for guidance based on
Early versus Late Discontinuation of Maintenance Therapy in ... - MDPI IFM_05-May 2022
Lenalidomide was the primary drug used for maintenance in this study. Key Findings:
One critical finding was an increased risk of developing a second primary malignancy (SPM) while on long-term lenalidomide maintenance. Patient Considerations